Schlagwort: crypto business

Veröffentlicht am

XRP climbs above $3 after ETF delay; Check forecast

Key takeaways

  • XRP is up nearly 2% in the last 24 hours and has climbed above $3.
  • The positive performance comes despite the SEC’s ETF delay.

SEC delays spot XRP ETF applications

XRP, the native coin of the Ripple network, is up nearly 2% in the last 24 hours as it bounces back from its recent low. The positive performance comes despite the United States Securities and Exchange Commission (SEC) delaying its decision on Canary Capital, CoinShares, Bitwise, Grayscale, and 21Shares’ spot XRP ETF applications.

The regulatory agency stated that it had extended its decision on the 21Shares Core XRP Trust from the set deadline of August 20, adding 60 days, setting the new deadline for October 19.

The SEC also delayed decisions on the 21Shares Trust, Grayscale, CoinShares, and Bitwise XRP ETF filings. The delay will provide the SEC enough time to seek public opinion on the proposal and assess any regulatory concerns associated with the Exchange Act.

Analysts expect the SEC to issue final decisions on all eight pending spot ETF applications, including Franklin Templeton, REX-Osprey, WisdomTree, and five others, by October 18.

XRP aims for $3.3 as the market slowly recovers

The XRP/USD 4-hour chart remains bullish and efficient despite XRP’s recent poor performance. The long-term trend remains bullish as XRP looks to set a new all-time high in the near to medium term. 

After holding around the $2.9 support, XRP could rally higher in the short term. The technical indicators are still bearish but point to signs of growing momentum. The MACD lines are within the bearish region, but could soon crossover into the positive zone. The RSI of 43 shows that XRP is not in the oversold region, and bulls could regain control with ease.

XRP/USD 4H Chart

If the recovery improves, XRP could surge past the first major resistance level at $3.39 in the next few hours or days. Support from the broader market would allow it to surpass its recent high of $3.66.

However, if the bearish trend grows stronger, XRP could retest the $2.72 support level over the next few days. The low of $2.08 created last month remains strong and could stand in the short to medium term.

The post XRP climbs above $3 after ETF delay; Check forecast appeared first on CoinJournal.

Veröffentlicht am

Bio Protocol hits 6-month high as harmonic pattern signals further upside

  • Bio Protocol funds $80K brain health trial, earning CLAW royalty tokens.
  • Staked BIO tokens rise to 125M, tightening supply and boosting demand.
  • Harmonic chart pattern signals a possible BIO price rally toward $0.1787.

The Bio Protocol (BIO) token has regained strong momentum after a sharp pullback earlier this month, climbing to a six-month high of $0.1514 before settling near $0.138.

The recovery follows a string of bullish catalysts, ranging from real-world biotech partnerships to a surge in staking activity, while traders are now watching technical signals that hint at further upside.

BIO price recovery sparks fresh momentum

After dropping to $0.0962 during the recent correction, BIO has staged an impressive rebound of more than 50% in a matter of days.

The strong recovery comes at a time when the broader crypto market has been under selling pressure, yet Bio Protocol has managed to move against the trend.

At press time, the token was trading nearly 100% higher on the month, underscoring its growing resilience.

Trading activity has also intensified. Daily volumes have spiked by more than 700% last week, crossing $440 million as new investors piled in.

This sharp increase in liquidity has strengthened confidence that BIO’s market depth is improving, making it more attractive for both retail and institutional traders.

Clinical trial funding lifts sentiment

One of the strongest drivers of BIO’s price rally has been the announcement of its first major biotech initiative.

Through its partner Cerebrum DAO, the Bio Protocol community approved $80,000 in funding for a Phase 2 human clinical trial of Percepta, a supplement targeting memory loss and neurodegeneration.

The deal not only gives Bio Protocol direct exposure to real-world biotech outcomes but also provides it with CLAW tokens.

These tokens are tied to royalties from Percepta sales, creating a potential revenue-sharing model that sets BIO apart from other speculative altcoins.

Investors see this as a sign that the project is delivering on its promise to link decentralised finance with biotech innovation.

BIO token staking reduces supply pressure

Another factor supporting BIO’s price is the steady growth in token staking.

The amount of staked BIO tokens has climbed to 125 million, representing about 3.5% of the circulating supply.

This is a significant jump from 25 million staked tokens earlier in August.

By staking, holders earn BioXP, which provides access to new ecosystem assets such as CLAW. More importantly, staking reduces the liquid supply on exchanges.

As a result, when demand rises, the price impact is magnified. Traders are already drawing comparisons to earlier DeFi tokens where similar dynamics sparked explosive rallies.

Technical setup points to higher targets

From a technical perspective, BIO has cleared several key resistance levels. It moved above the 7-day simple moving average at $0.116 and broke through the 23.6% Fibonacci retracement at $0.128.

The next resistance sits near $0.145, with momentum indicators suggesting strong buying pressure despite a relative strength index that hovers near overbought territory.

Adding to this outlook, analysts have identified a harmonic ABCD pattern unfolding on the 4-hour chart.

Bio Protocol price analysis

The harmonic ABCD pattern began with a rally from $0.0559 to $0.0956 before retracing and launching into a bullish CD-leg.

The extension of this structure projects an upside target near $0.1800, which traders are closely monitoring as the next profit-taking zone.

Bio Protocol price outlook remains cautiously bullish

While the harmonic setup points to further upside, traders remain alert to the possibility of consolidation.

A failure to hold above the 50-period moving average, currently near $0.1159, could open the door to short-term corrections.

Still, the combination of real-world utility, staking-driven scarcity, and a favourable technical structure has left sentiment firmly bullish.

Bio Protocol’s six-month high marks an important milestone for a token launched less than a year ago.

But whether it can sustain this rally will depend on both the outcome of the Percepta trial and the broader adoption of decentralised science models.

The post Bio Protocol hits 6-month high as harmonic pattern signals further upside appeared first on CoinJournal.

Veröffentlicht am

XRP price forecast points to a possible 777% surge to $28

  • XRP could potentially rise from around $3 to $28, representing a 777% increase.
  • Financial institutions are increasingly adopting XRP for cross-border payments.
  • The projected surge depends on favorable market conditions and continued adoption.

XRP is once again at the centre of market discussions after crypto strategist @egragcrypto shared a prediction suggesting the token could rally by as much as 777%, potentially reaching $28.

The digital asset, currently trading at around $3.01, has attracted renewed attention from both investors and analysts across global markets.

XRP price
Source: CoinMarketCap

This projection comes against a backdrop of historical price cycles, ongoing legal clarity from Ripple’s battle with the US Securities and Exchange Commission (SEC), and increasing institutional adoption of blockchain-based settlement solutions.

The combination of technical chart patterns and real-world developments is driving speculation on whether XRP can repeat its past performance and set new all-time highs.

XRP cycles show patterns behind $28 forecast

According to the analysis, XRP’s price history reveals three distinct cycles. The first, during the 2017–2018 boom, saw the token move from just a few cents to over $3.00 before the wider crypto market collapsed.

The second occurred between 2020 and 2021, when XRP staged a strong rebound despite Ripple being caught in an SEC lawsuit.

Egrag’s cycle analysis now points to a potential third phase. XRP has been consolidating near multi-year highs, with the 777% target at $28.16 projected if the historical pattern plays out once again.

The forecast has spread widely across social media, with the tweet by @egragcrypto fuelling further debate among market watchers and crypto traders worldwide.

Ripple’s legal win and institutional partnerships

Momentum around XRP has also been supported by developments outside of charts. A key turning point came in 2023, when Ripple secured a partial court victory against the SEC.

The ruling determined that XRP was not considered a security when traded on exchanges, removing a major source of regulatory uncertainty. This outcome provided banks and institutions with the confidence to engage with the token, reviving its role as a settlement asset.

Ripple has since expanded its network of financial partnerships across global markets, with institutions exploring XRP’s potential for cross-border payments.

Despite challenges, XRP has consistently maintained its place in the top 10 cryptocurrencies by market capitalisation. At present, the token is up roughly 1.66% today, with trading volumes reflecting solid interest from both retail and institutional investors.

XRP prediction requires favourable conditions

While the 777% projection to $28 has gained attention, analysts note that such a move would require favourable conditions, including wider crypto market growth, regulatory stability, and continued adoption by financial institutions.

The size of the rally means that the prediction remains highly ambitious, but XRP’s resilience has kept it in the spotlight.

Sustained performance in trading volumes, combined with XRP’s ability to maintain relevance despite legal hurdles, has encouraged closer monitoring of the asset.

Whether or not the cycle analysis proves accurate, XRP continues to demonstrate significant staying power in an evolving global cryptocurrency market that is increasingly shaped by institutional participation and long-term investor interest worldwide.

The post XRP price forecast points to a possible 777% surge to $28 appeared first on CoinJournal.

Veröffentlicht am

BTC slips 1.1% to $116K as traders brace for August weakness

  • Crypto markets show a split between institutional bulls and retail bears.
  • Prediction markets signal a bearish end to August for Bitcoin.
  • Derivatives data shows caution, with funding rates turning negative.

A profound and unsettling divide is splitting the cryptocurrency market in two as the trading day begins in East Asia.

While the world’s largest institutions are quietly building their positions for a long-term rally, a wave of short-term fear is gripping the retail and derivatives markets, creating a tense tug-of-war that is pulling prices lower.

As the morning session unfolds, Bitcoin is trading at $116,263, down 1.1% and 2% lower on the week, while ETH sits at $4,322, seeing a sharper 3.8% drop in the last 24 hours.

The broader market is feeling the pressure, with the CoinDesk 20 (CD20) index down 2.4%. This nervous price action is a direct reflection of a market caught between two powerful, opposing narratives.

A tale of two markets

On one side, the conviction of institutional players remains unshakable. The Singapore-based market maker Enflux described the dynamic perfectly in a note to CoinDesk. 

“The market remains caught between strong underlying institutional conviction, highlighted by Strategy Inc.’s additional 430 BTC purchase and structural financing shift, and a lack of immediate retail follow-through,” the firm wrote.

Enflux points to asset manager VanEck’s reiterated $180,000 year-end bitcoin target as clear evidence that the market’s giants are positioning for a significant move higher.

On the other side, however, the retail-driven narratives that often fuel explosive rallies have fizzled, with potential ETFs for assets like XRP and DOGE stalled by SEC delays.

One notable exception to this trend is Solana, which Enflux noted continues to show “quiet strength,” driven by its dominance in USDC transfers and its growing share of new token issuance via platforms like PumpFun.

Whispers of warning from the derivatives market

This lack of broad participation is creating a vacuum that is being filled with caution. Prediction markets are now flashing bearish signals for the remainder of August.

On Polymarket, the odds now favor a month-end close for BTC below $111,000, with a 34% probability.

The derivatives market is telling a similar story of defensive posturing.

The analytics firm QCP reported in a recent market update that perpetual funding rates—a key indicator of trader sentiment—turned negative over the weekend, a setup that has preceded pullbacks in the past.

Furthermore, options skews now clearly favor puts (bets on a price decline) across all timeframes.

The calm before the storm: all eyes on jackson hole

The result is a market that feels structurally sound at its core but is tactically fragile and defensive on the surface.

This nervous energy is building ahead of the week’s main event: the Jackson Hole symposium, where Fed Chair Jerome Powell is expected to deliver a pivotal speech.

Traders are anxiously awaiting guidance on how the central bank will navigate higher-than-expected inflation, especially under the glare of a White House that continues to challenge its neutrality.

While the long-term foundation for a broader rally—fueled by four-year highs in crypto search interest and the promising GENIUS Act making its way through Washington—is still being laid, the immediate future appears uncertain.

For now, the conviction is concentrated among the giants, while the rest of the market holds its breath, waiting for a spark.

The post BTC slips 1.1% to $116K as traders brace for August weakness appeared first on CoinJournal.

Veröffentlicht am

Bio Protocol defies crypto downturn with a 720% surge in volume

  • Bio Protocol price rose more than 50% as bulls defied broader market selling to hit $1.46
  • Despite overall sell-off pressure, BIO price is up double-digits in 24 hours as volume spikes 720%.
  • BIO has benefited from key network developments, including staking and partnerships.

The price of Bio Protocol (BIO) shrugged off a broader crypto downturn to lead 24-hour gainers on Monday.

With the project that’s targeting the decentralized science (DeSci) ecosystem hitting key milestones recently, buyers have upped the ante by pushing BIO higher.

BIO price surges nearly 50% to lead top gainers

The Bio Protocol (BIO) price saw a significant surge as top altcoins struggled amid profit taking.

With Bitcoin shedding gains to below $116k and Ethereum dipping to $4,200, the BIO token climbed nearly 50% to lead the top gainers.

Per CoinMarketCap, this put the decentralized science project among the 500 largest cryptocurrencies by market capitalization.

Notably, Bio Protocol traded up from lows of $0.10 and topped $0.15.

The uptick meant BIO defied overall declines across the market, with gains coming as its 24-hour volume spiked 720% to over $393 million.

Although BIO remains double-digits up with over 21% upside in the past 24 hours, it has dropped from the $0.15 high. This shows the overall market weakness as sellers drive it to around $0.12.

Bio Protocol price chart by CoinMarketCap

Bio Protocol has hit key network milestones

Bio Protocol has gained amid significant network milestones in the past week.

As the DeSci economy picks up, the Bio Protocol team has positioned the project for greater traction with the launch of Bio Markets.

The goal is a platform that brings real-time insights into projects within the Bio Protocol ecosystem.

Markets bring growth trends and in-app trading for BioDAOs, and Bio plans to expand trading capabilities to IP-Tokens and new BioAgents.

Staking activity has also soared, with over 125 million BIO tokens staked, up to 3.5% of the circulating supply.

As the Bio team recently noted, staking generates BioXP, a key component for participating in upcoming Ignition Sales.

Unveiling of Yapping BioXP, also set to go live in the app this week, includes a boost campaign for BioAgents, further incentivizing community engagement.

What does it mean for BIO price?

Bio Protocol also hit a major milestone with CLAW, Percepta’s IP-Token.

Meanwhile, Molecule’s development of its v2 protocol targets the bridging of traditional corporate structures with DeSci.

Listing on Coinbase, the top U.S.-based crypto exchange, allows for further institutional adoption.

“From Bio V2’s launch and 100M+ BIO staked, to Coinbase listing $BIO and VitaDAO advancing longevity trials, the past month marked key steps in AI-driven science and DeSci adoption,” Bio Protocol recently posted.

Achievement of these milestones could help bolster the price of BIO.

The post Bio Protocol defies crypto downturn with a 720% surge in volume appeared first on CoinJournal.